Skip to content
healthcare.dev

Allergy Relief

NDC 76162-915, Levocetirizine Dihydrochloride USP, 5 mg, tablet, coated, from Topco Associates, LLC.

Product NDC
76162-915
Status
Listed
Labeler
Topco Associates, LLC
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213513
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76162-915 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOCETIRIZINE DIHYDROCHLORIDE5 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
76162-915-35761620915351 BOTTLE in 1 CARTON (76162-915-35) / 35 TABLET, COATED in 1 BOTTLE
76162-915-80761620915801 BOTTLE in 1 CARTON (76162-915-80) / 80 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 76162-915 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76162-915 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76162-915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.